Innovative and cutting-edge technology transforms functional live-cell analysis by enabling precise, flexible, and scalable end-to-end immuno-oncology, antibody, and cell therapy discovery.
Not all patients respond well to chimeric antigen receptor (CAR) T cell therapies, which reprogram a patient’s own immune cells to recognize and attack cancer. A way to optimize these treatments is to ...
The identification of reliable biomarkers from peripheral blood is crucial for improving disease diagnosis and monitoring. Spectral flow cytometry has emerged as a powerful tool for high-dimensional ...
The proposed approach involves causing random mutations on human derived receptor H 3 R and introducing the altered genetic code into yeast cultures. This allows for the convenient screening of ...
RNA is thought to be a stay-at-home kind of molecule, often comfortably confined within the cell’s interior. So, when RNA molecules were detected on the surface of several cell types, researchers ...
In 2021, research led by Ryan Flynn, MD, PhD, and his mentor, Nobel laureate Carolyn Bertozzi, PhD, opened a new chapter in biology, characterizing a new kind of player on the cell surface: glycoRNAs.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback